Earnings Reportpositive

Earnings Report

Other upcoming events for KNSA

Phase 2 ReadoutPhase 2 Readout: kpl-387
Phase 3 ReadoutPhase 3 Topline: A Phase 2/3 Efficacy and Safety Study of KPL-387 Treatment in Participants With Recurrent Pericardit

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — KNSA Earnings Report | BioSniper